New onset myasthenia gravis in a patient with non small cell lung cancer treated with lorlatinib a novel anti-cancer agent

J Neurol Sci. 2018 Sep 15:392:100-101. doi: 10.1016/j.jns.2018.06.024. Epub 2018 Jul 2.

¹ Department of Neurology, Wayne State University/Detroit Medical Center, United States. Electronic address: aaron.desai@wayne.edu.
² Department of Neurology, Wayne State University/Detroit Medical Center, United States.
³ Karmanos Cancer Institute, Department of Oncology, Wayne State University, United States.
⁴ Department of Neurology, Wayne State University/Detroit Medical Center, United States; Department of Microbiology, Immunology and Biochemistry, Wayne State University, United States.

No abstract available

Keywords: Lorlatinib; Myasthenia gravis; Non-small cell lung cancer; Tyrosine kinase inhibitor.

Publication types